Piggyback IOL effective in highly myopic eyes

Article

Piggyback multifocal IOLs used for a hyperopic-presbyopic surprise after cataract surgery are successful in highly myopic eyes, claims a study in the Journal of the British Contact Lens Association.

Piggyback multifocal IOLs used for a hyperopic-presbyopic surprise after cataract surgery are successful in highly myopic eyes, claims a study in the Journal of the British Contact Lens Association.

A team managed by Dr Valentin Huerva, Ophthalmology Department, Universitary Hospital Arnau de Vilanova, Lleida, Spain, completed a case report on a 43-year-old woman with high myopia who also presented with dense subcapsular cataracts.

The refractive result was to achieve a spherical equivalent refractive error of +2.25. The team used a refractive multifocal +3 D Sulcoflex 653F to overcome refractive surprise, with an additional 3.5 D for near vision. This achieved a best-corrected visual acuity of 20/40 and good intermediate vision for computer work.

The IOL enables good near-intermediate visual acuity and spectacle independence in highly myopic eyes with good near visual acuity. It could be possible to correct residual refractive errors by implanting the IOL following earlier implantation of a monofocal IOL.

To read the abstract please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.